Further, we and others have shown that CCR9-CCL25 interaction supports cancer cell survival by inhibiting chemotherapy-induced apoptosis in a PI3K-/Akt-dependent and focal adhesion kinase (FAK)-independent manner [4,12-17]. This evidence concerns the gene CCR9 and cancer.